Vitamin D deficiency and acute lung injury

Inflammation and Allergy - Drug Targets

Volumn 12, Issue 4, 2013, Pages 253-261

  Parekh, Dhruv ^a,b   Thickett, David R ^a   Turner, Alice M ^a,c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

Acute lung injury; Adult respiratory distress syndrome; Cholecalciferol; Etiology; Pharmacology

Indexed keywords

25 HYDROXYVITAMIN D; BETA DEFENSIN 2; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; COLECALCIFEROL; GELATINASE A; GELATINASE B; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; MATRILYSIN; NEUTROPHIL COLLAGENASE; REACTIVE OXYGEN METABOLITE; THROMBOCYTE ACTIVATING FACTOR; VASCULOTROPIN; VITAMIN D;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; AUTOPHAGY; DRUG MEGADOSE; ESOPHAGUS RESECTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG EDEMA; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS; PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; SUNLIGHT; VITAMIN D DEFICIENCY; WOUND HEALING;

ACUTE LUNG INJURY; ANIMALS; HUMANS; INFLAMMATION; LUNG; RESPIRATORY DISTRESS SYNDROME, ADULT; VITAMIN D DEFICIENCY;

EID: 84882806383     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/18715281113129990049     Document Type: Review

References (96)

1. Parekh, D.; Dancer, R. C.; Thickett, D. R. Acute lung injury. Clin. Med., 2011, 11(6), 615-618.
2. Ware, L. B.; Matthay, M. A. The acute respiratory distress syndrome. N. Engl. J. Med., 2000, 342(18), 1334-1349.
3. Ashbaugh, D. G.; Bigelow, D. B.; Petty, T. L.; Levine, B. E. Acute respiratory distress in adults. Lancet, 1967, 2(7511), 319-323.
4. Bernard, G. R.; Artigas, A.; Brigham, K. L.; Carlet, J.; Falke, K.; Hudson, L.; Lamy, M.; Legall, J. R.; Morris, A.; Spragg, R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med., 1994, 149(3 Pt 1), 818-824.
5. Esteban, A.; Fernández-Segoviano, P.; Frutos-Vivar, F.; Aramburu, J. A.; Nájera, L.; Ferguson, N. D.; Alía, I.; Gordo, F.; Ríos, F. Comparison of clinical criteria for the acute respiratory distress syndrome with autopsy findings. Ann. Intern. Med., 2004, 141(6), 440-445.
6. Rubenfeld, G. D.; Herridge, M. S. Epidemiology and outcomes of acute lung injury. Chest, 2007, 131(2), 554-562.
7. Lewandowski, K.; Lewandowski, M. Epidemiology of ARDS. Minerva Anestesiol., 2006, 72(6), 473-477.
8. Phua, J.; Badia, J. R.; Adhikari, N. K.; Friedrich, J. O.; Fowler, R. A.; Singh, J. M.; Scales, D. C.; Stather, D. R.; Li, A.; Jones, A.; Gattas, D. J.; Hallett, D.; Tomlinson, G.; Stewart, T. E.; Ferguson, N. D. Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review. Am. J. Respir. Crit. Care Med., 2009, 179(3), 220-227.
9. Matthay, M. A.; Brower, R. G.; Carson, S.; Douglas, I. S.; Eisner, M.; Hite, D.; Holets, S.; Kallet, R. H.; Liu, K. D.; MacIntyre, N.; Moss, M.; Schoenfeld, D.; Steingrub, J.; Thompson, B. T. Randomized, placebo-controlled clinical trial of an aerosolized beta(2)-agonist for treatment of acute lung injury. Am. J. Respir. Crit. Care Med., 2011, 184(5), 561-568
10. Gao Smith, F.; Perkins, G. D.; Gates, S.; Young, D.; McAuley, D. F.; Tunnicliffe, W.; Khan, Z.; Lamb, S. E. Effect of intravenous beta-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet, 2012, 379(9812), 229-235.
11. Herridge, M. S.; Tansey, C. M.; Matte, A.; Tomlinson, G.; Diaz-Granados, N.; Cooper, A.; Guest, C. B.; Mazer, C. D.; Mehta, S.; Stewart, T. E.; Kudlow, P.; Cook, D.; Slutsky, A. S.; Cheung, A. M. Functional disability 5 years after acute respiratory distress syndrome. N. Engl. J. Med., 2011, 364(14), 1293-1304.
12. Hansdottir, S.; Monick, M. M.; Hinde, S. L.; Lovan, N.; Look, D. C.; Hunninghake, G. W. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J. Immunol., 2008, 181(10), 7090-7099.
13. Adams, J. S.; Sharma, O. P.; Gacad, M. A.; Singer, F. R. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J. Clin. Invest., 1983, 72(5), 1856-1860.
14. Chen, S.; Sims, G. P.; Chen, X. X.; Gu, Y. Y.; Lipsky, P. E. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol., 2007, 179(3), 1634-1647.
15. Sigmundsdottir, H.; Pan, J.; Debes, G. F.; Alt, C.; Habtezion, A.; Soler, D.; Butcher, E. C. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat. Immunol., 2007, 8(3), 285-293.
16. Wood, A. M.; Bassford, C.; Webster, D.; Newby, P.; Rajesh, P.; Stockley, R. A.; Thickett, D. R. Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages. Thorax, 2011, 66(3), 205-210.
17. Chishimba, L.; Thickett, D. R.; Stockley, R. A.; Wood, A. M. The vitamin D axis in the lung: a key role for vitamin D-binding protein. Thorax, 2010, 65(5), 456-462.
18. Holick, M. F. Vitamin D deficiency. N. Engl. J. Med., 2007, 357(3), 266-281
19. Adams, J. S.; Hewison, M. Update in vitamin D. J. Clin. Endocrinol. Metab., 2010, 95(2), 471-478.
20. Ginde, A. A.; Liu, M. C.; Camargo, C. A. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch. Intern. Med., 2009, 169(6), 626-632.
21. Hyppönen, E.; Power, C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am. J. Clin. Nutr., 2007, 85(3), 860-868.
22. Cannell, J. J.; Vieth, R.; Umhau, J. C.; Holick, M. F.; Grant, W. B.; Madronich, S.; Garland, C. F.; Giovannucci, E. Epidemic influenza and vitamin D. Epidemiol. Infect., 2006, 134(6), 1129-1140
23. Muhe, L.; Lulseged, S.; Mason, K. E.; Simoes, E. A. Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet, 1997, 349(9068), 1801-1804.
24. Coussens, A. K.; Wilkinson, R. J.; Hanifa, Y.; Nikolayevskyy, V.; Elkington, P. T.; Islam, K.; Timms, P. M.; Venton, T. R.; Bothamley, G. H.; Packe, G. E.; Darmalingam, M.; Davidson, R. N.; Milburn, H. J.; Baker, L. V.; Barker, R. D.; Mein, C. A.; Bhaw-Rosun, L.; Nuamah, R.; Young, D. B.; Drobniewski, F. A.; Griffiths, C. J.; Martineau, A. R. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc. Natl. Acad Sci. U S A, 2012, 109(38), 15449-15454.
25. Finklea, J. D.; Grossmann, R. E.; Tangpricha, V. Vitamin D and chronic lung disease: a review of molecular mechanisms and clinical studies. Adv. Nutr., 2011, 2(3), 244-253.
26. Cameron F. Gunville, Peter M. Mourani, and Adit A. Ginde. The Role of Vitamin D in Prevention and Treatment of Infection. Inflamm. Allergy Drug Targets, 2013, 12(4), 239-245.
27. Lee, P.; Eisman, J. A.; Benter, J. R. Vitamin D deficiency in critically ill patients. N. Engl. J. Med., 2009, 360(18), 1912-1914.
28. Braun, A.; Chang, D.; Mahadevappa, K.; Gibbons, F. K.; Liu, Y.; Giovannucci, E.; Christopher, K. B. Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill. Crit. Care Med., 2011, 39(4), 671-677
29. Braun, A. B.; Gibbons, F. K.; Litonjua, A. A.; Giovannucci, E.; Christopher, K. B. Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality. Crit. Care Med., 2012, 40(1), 63-72
30. Amrein, K.; Sourij, H.; Wagner, G.; Holl, A.; Pieber, T. R.; Smolle, K. H.; Stojakovic, T.; Schnedl, C.; Dobnig, H. Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study. Crit. Care, 2011, 15(2), R104.
31. Perkins, G. D.; Chatterjie, S.; McAuley, D. F.; Gao, F.; Thickett, D. R. Role of nonbronchoscopic lavage for investigating alveolar inflammation and permeability in acute respiratory distress syndrome. Crit. Care Med., 2006, 34(1), 57-64
32. Grommes, J.; Soehnlein, O. Contribution of neutrophils to acute lung injury. Mol. Med., 2011, 17(3-4), 293-307.
33. Martinez, F. O.; Sica, A.; Mantovani, A.; Locati, M. Macrophage activation and polarization. Front. Biosci., 2008, 13, 453-4561.
34. Herold, S.; Mayer, K.; Lohmeyer, J. Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair. Front. Immunol., 2011, 2, 65
35. Laskin, D. L.; Sunil, V. R.; Gardner, C. R.; Laskin, J. D. Macrophages and tissue injury: agents of defense or destruction? Annu. Rev. Pharmacol. Toxicol., 2011, 51, 267-88.
36. D'Alessio, F. R.; Tsushima, K.; Aggarwal, N. R.; West, E. E.; Willett, M. H.; Britos, M. F.; Pipeling, M. R.; Brower, R. G.; Tuder, R. M.; McDyer, J. F.; King, L. S. CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J. Clin. Invest., 2009, 119(10), 2898-2913.
37. O'Kane, C. M.; McKeown, S. W.; Perkins, G. D.; Bassford, C. R.; Gao, F.; Thickett, D. R.; McAuley, D. F. Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome. Crit. Care Med., 2009, 37(7), 2242-2249.
38. Clairmont, A.; Tessman, D.; Stock, A.; Nicolai, S.; Stahl, W.; Sies, H. Induction of gap junctional intercellular communication by vitamin D in human skin fibroblasts is dependent on the nuclear Induction of gap junctional intercellular communication by vitamin D in human skin fibroblasts is dependent on the nuclear vitamin D receptor. Carcinogenesis, 1996, 17(6), 1389-1391
39. Gniadecki, R.; Gajkowska, B.; Hansen, M. 1,25-dihydroxyvitamin D3 stimulates the assembly of adherens junctions in keratinocytes: involvement of protein kinase C. Endocrinology, 1997, 138(6), 2241-2248
40. Pálmer, H. G.; González-Sancho, J. M.; Espada, J.; Berciano, M. T.; Puig, I.; Baulida, J.; Quintanilla, M.; Cano, A.; de Herreros, A. G.; Lafarga, M.; Muñoz, A. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J. Cell Biol., 2001, 154(2), 369-387
41. Kong, J.; Zhang, Z.; Musch, M. W.; Ning, G.; Sun, J.; Hart, J.; Bissonnette, M.; Li, Y. C. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am. J. Physiol. Gastrointest. Liver Physiol., 2008, 294(1), G208-216.
42. Hewison, M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol. Metab. Clin. North Am., 2010, 39(2), 365-379, table of contents.
43. Wang, T. T.; Nestel, F. P.; Bourdeau, V.; Nagai, Y.; Wang, Q.; Liao, J.; Tavera-Mendoza, L.; Lin, R.; Hanrahan, J. W.; Mader, S.; White, J. H.; Hanrahan, J. H. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol., 2004, 173(5), 2909-2912.
44. Zanetti, M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol., 2004, 75(1), 39-48.
45. Hansdottir, S.; Monick, M. M.; Lovan, N.; Powers, L.; Gerke, A.; Hunninghake, G. W. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J. Immunol., 2010, 184(2), 965-974.
46. Fahy, R. J.; Wewers, M. D. Pulmonary defense and the human cathelicidin hCAP-18/LL-37. Immunol. Res., 2005, 31(2), 75-89.
47. Shaykhiev, R.; Beisswenger, C.; Kandler, K.; Senske, J.; Puchner, A.; Damm, T.; Behr, J.; Bals, R. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am. J. Physiol. Lung Cell Mol. Physiol., 2005, 289(5), L842-848.
48. Alalwani, S. M.; Sierigk, J.; Herr, C.; Pinkenburg, O.; Gallo, R.; Vogelmeier, C.; Bals, R. The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils. Eur. J. Immunol., 2010, 40(4), 1118-1126.
49. Kreutz, M.; Andreesen, R.; Krause, S. W.; Szabo, A.; Ritz, E.; Reichel, H. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood, 1993, 82(4), 1300-1307.
50. Koeffler, H. P.; Reichel, H.; Bishop, J. E.; Norman, A. W. Gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochem. Biophys. Res. Commun., 1985, 127(2), 596-603.
51. Herr, C.; Branschied, M.; Vogelmeier, C.; Bals, R. ERS Barcelona meeting 2010, p 4349.
52. Cohen, M. S.; Mesler, D. E.; Snipes, R. G.; Gray, T. K. 1,25-Dihydroxyvitamin D3 activates secretion of hydrogen peroxide by human monocytes. J. Immunol., 1986, 136(3), 1049-1053.
53. Sun, J.; Kong, J.; Duan, Y.; Szeto, F. L.; Liao, A.; Madara, J. L.; Li, Y. C. Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor. Am. J. Physiol. Endocrinol. Metab., 2006, 291(2), E315-22
54. Sadeghi, K.; Wessner, B.; Laggner, U.; Ploder, M.; Tamandl, D.; Friedl, J.; Zugel, U.; Steinmeyer, A.; Pollak, A.; Roth, E.; Boltz-Nitulescu, G.; Spittler, A. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur. J. Immunol., 2006, 36(2), 361-370.
55. Beard, J. A.; Bearden, A.; Striker, R. Vitamin D and the anti-viral state. J. Clin. Virol., 2011, 50(3), 194-200
56. Hansdottir, S.; Monick, M. M.; Lovan, N.; Powers, L.; Gerke, A.; Hunninghake, G. W. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J. Immunol., 2010, 184(2), 965-974.
57. Takahashi, K.; Nakayama, Y.; Horiuchi, H.; Ohta, T.; Komoriya, K.; Ohmori, H.; Kamimura, T. Human neutrophils express messenger RNA of vitamin D receptor and respond to 1alpha,25-dihydroxyvitamin D3. Immunopharmacol. Immunotoxicol., 2002, 24(3), 335-347.
58. Zhou, X.; Bailey-Bucktrout, S.; Jeker, L. T.; Bluestone, J. A. Plasticity of CD4(+) FoxP3(+) T cells. Curr. Opin. Immunol., 2009, 21(3), 281-285
59. Zhou, L.; Chong, M. M.; Littman, D. R. Plasticity of CD4+ T cell lineage differentiation. Immunity, 2009, 30(5), 646-655
60. Jeffery, L. E.; Burke, F.; Mura, M.; Zheng, Y.; Qureshi, O. S.; Hewison, M.; Walker, L. S.; Lammas, D. A.; Raza, K.; Sansom, D. M. 1,25-Dihydroxyvitamin D(3) and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J. Immunol., 2009, 183(9), 5458-5467.
61. Hoyer-Hansen, M.; Nordbrandt, S. P.; Jaattela, M. Autophagy as a basis for the health-promoting effects of vitamin D. Trends Mol. Med., 2010, 16(7), 295-302
62. Wu, S.; Sun, J. Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection. Discov. Med., 2011, 11(59), 325-335.
63. Ryter, S. W.; Choi, A. M. Autophagy in the lung. Proc. Am. Thorac. Soc., 2010, 7(1), 13-21.
64. Wilson, C. L.; Ouellette, A. J.; Satchell, D. P.; Ayabe, T.; López-Boado, Y. S.; Stratman, J. L.; Hultgren, S. J.; Matrisian, L. M.; Parks, W. C. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science, 1999, 286(5437), 113-117.
65. Parks, W. C. Matrix metalloproteinases in lung repair. Eur. Respir. J. Suppl., 2003, 44, 36s-38s.
66. Albaiceta, G. M.; Gutiérrez-Fernández, A.; Parra, D.; Astudillo, A.; García-Prieto, E.; Taboada, F.; Fueyo, A. Lack of matrix metalloproteinase-9 worsens ventilator-induced lung injury. Am. J. Physiol. Lung Cell Mol. Physiol., 2008, 294(3), L535-543.
67. Yamashita, C. M.; Dolgonos, L.; Zemans, R. L.; Young, S. K.; Robertson, J.; Briones, N.; Suzuki, T.; Campbell, M. N.; Gauldie, J.; Radisky, D. C.; Riches, D. W.; Yu, G.; Kaminski, N.; McCulloch, C. A.; Downey, G. P. Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis. Am. J. Pathol., 2011, 179(4), 1733-1745.
68. Song, Y.; Qi, H.; Wu, C. Effect of 1,25-(OH)2D3 (a vitamin D analogue) on passively sensitized human airway smooth muscle cells. Respirology, 2007, 12(4), 486-494.
69. Coussens, A.; Timms, P. M.; Boucher, B. J.; Venton, T. R.; Ashcroft, A. T.; Skolimowska, K. H.; Newton, S. M.; Wilkinson, K. A.; Davidson, R. N.; Griffiths, C. J.; Wilkinson, R. J.; Martineau, A. R. 1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection. Immunology, 2009, 127(4), 539-548.
70. González-López, A.; Albaiceta, G. M. Repair after acute lung injury: molecular mechanisms and therapeutic opportunities. Crit. Care, 2012, 16(2), 209.
71. Chen, S. F. 1 alpha, 25-Dihydroxyvitamin D3 decreased ICAM-1 and ELAM-1 expressions on pulmonary microvascular endothelial cells and neutrophil motivation. J. Steroid Biochem. Mol. Biol., 1995, 52(1), 67-70.
72. Speeckaert, M.; Huang, G.; Delanghe, J. R.; Taes, Y. E. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin. Chim. Acta, 2006, 372(1-2), 33-42.
73. Dahl, B.; Schiodt, F. V.; Ott, P.; Wians, F.; Lee, W. M.; Balko, J.; O'Keefe, G. E. Plasma concentration of Gc-globulin is associated with organ dysfunction and sepsis after injury. Crit. Care Med., 2003, 31(1), 152-156.
74. Adams, J. S.; Hewison, M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat. Clin. Pract. Endocrinol. Metab., 2008, 4(2), 80-90.
75. Cecchi, A.; Bonizzoli, M.; Douar, S.; Mangini, M.; Paladini, S.; Gazzini, B.; Deglinnocenti, S.; Linden, M.; Zagli, G.; Peris, A. Vitamin D deficiency in septic patients at ICU admission is not a mortality predictor. Minerva Anestesiol., 2011, 77(12), 1184-1189.
76. Flynn, L.; Zimmerman, L. H.; McNorton, K.; Dolman, M.; Tyburski, J.; Baylor, A.; Wilson, R.; Dolman, H. Effects of vitamin D deficiency in critically ill surgical patients. Am. J. Surg., 2012, 203(3), 379-382; discussion 382.
77. Jeng, L.; Yamshchikov, A. V.; Judd, S. E.; Blumberg, H. M.; Martin, G. S.; Ziegler, T. R.; Tangpricha, V. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J. Transl. Med., 2009, 7, 28.
78. Takano, Y.; Mitsuhashi, H.; Ueno, K. 1alpha,25-Dihydroxyvitamin D(3) inhibits neutrophil recruitment in hamster model of acute lung injury. Steroids, 2011, 76(12), 1305-1309.
79. Shih, P. K.; Chen, Y. C.; Huang, Y. C.; Chang, Y. T.; Chen, J. X.; Cheng, C. M. Pretreatment of vitamin D3 ameliorates lung and muscle injury induced by reperfusion of bilateral femoral vessels in a rat model. J. Surg. Res., 2011, 171(1), 323-328.
80. Yazici, G.; Yildiz, F.; Iskit, A.; Erdemli, E.; Surucu, S.; Firat, P.; Hayran, M.; Ozyigit, G.; Cengiz, M. The effect of vitamin D prophylaxis on radiation induced pulmonary damage. J. Radiat. Res., 2011, 52(5), 616-621.
81. Klaff, L. S.; Gill, S. E.; Wisse, B. E.; Mittelsteadt, K.; Matute-Bello, G.; Chen, P.; Altemeier, W. A. Lipopolysaccharide-induced lung injury is independent of serum vitamin D concentration. PLoS One, 2012, 7(11), e49076.
82. Parekh, D.; Dancer, R.C.A.; Lax, S.; Cooper, M.S.; Martineau, A.R.; Fraser, W.D.; Tucker, O.; Alderson, D.; Perkins, G.D.; Gao-Smith, F.; Thickett, D.R. Vitamin D to prevent acute lung injury following oesophagectomy (VINDALOO): study protocol for a randomised placebo controlled trial. Trials, 2013, 14(1), 100.
83. Martineau, A. R.; Timms, P. M.; Bothamley, G. H.; Hanifa, Y.; Islam, K.; Claxton, A. P.; Packe, G. E.; Moore-Gillon, J. C.; Darmalingam, M.; Davidson, R. N.; Milburn, H. J.; Baker, L. V.; Barker, R. D.; Woodward, N. J.; Venton, T. R.; Barnes, K. E.; Mullett, C. J.; Coussens, A. K.; Rutterford, C. M.; Mein, C. A.; Davies, G. R.; Wilkinson, R. J.; Nikolayevskyy, V.; Drobniewski, F. A.; Eldridge, S. M.; Griffiths, C. J. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet, 2011, 377(9761), 242-250.
84. Black, P. N.; Scragg, R. Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest, 2005, 128(6), 3792-3798.
85. Porojnicu, A. C.; Robsahm, T. E.; Dahlback, A.; Berg, J. P.; Christiani, D.; Bruland, O. S.; Moan, J. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role? Lung Cancer, 2007, 55(3), 263-270
86. Pilz, S.; Tomaschitz, A.; Obermayer-Pietsch, B.; Dobnig, H.; Pieber, T. R. Epidemiology of vitamin D insufficiency and cancer mortality. Anticancer Res., 2009, 29(9), 3699-3704.
87. Brehm, J. M.; Schuemann, B.; Fuhlbrigge, A. L.; Hollis, B. W.; Strunk, R. C.; Zeiger, R. S.; Weiss, S. T.; Litonjua, A. A.; Group, C. A. M. P. R. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J. Allergy Clin. Immunol., 2010, 126(1), 52.e5-8.e5.
88. Nnoaham, K. E.; Clarke, A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int. J. Epidemiol., 2008, 37(1), 113-119.
89. Laaksi, I.; Ruohola, J. P.; Tuohimaa, P.; Auvinen, A.; Haataja, R.; Pihlajamäki, H.; Ylikomi, T. An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am. J. Clin. Nutr., 2007, 86(3), 714-717.
90. Hughes, D. A.; Norton, R. Vitamin D and respiratory health. Clin. Exp. Immunol., 2009, 158(1), 20-25.
91. Sutherland, E. R.; Goleva, E.; Jackson, L. P.; Stevens, A. D.; Leung, D. Y. Vitamin D levels, lung function, and steroid response in adult asthma. Am. J. Respir. Crit. Care Med., 2010, 181(7), 699-704.
92. Xystrakis, E.; Kusumakar, S.; Boswell, S.; Peek, E.; Urry, Z.; Richards, D. F.; Adikibi, T.; Pridgeon, C.; Dallman, M.; Loke, T. K.; Robinson, D. S.; Barrat, F. J.; O'Garra, A.; Lavender, P.; Lee, T. H.; Corrigan, C.; Hawrylowicz, C. M. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J. Clin. Invest., 2006, 116(1), 146-155.
93. Barnes, P. J.; Adcock, I. M. Glucocorticoid resistance in inflammatory diseases. Lancet, 2009, 373(9678), 1905-1917.
94. Lehouck, A.; Mathieu, C.; Carremans, C.; Baeke, F.; Verhaegen, J.; Van Eldere, J.; Decallonne, B.; Bouillon, R.; Decramer, M.; Janssens, W. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann. Intern. Med., 2012, 156(2), 105-114.
95. Mercer, P. F.; Shute, J. K.; Bhowmik, A.; Donaldson, G. C.; Wedzicha, J. A.; Warner, J. A. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation. Respir. Res., 2005, 6, 151.
96. Liu, P. T.; Modlin, R. L. Human macrophage host defense against Mycobacterium tuberculosis. Curr. Opin. Immunol., 2008, 20(4), 371-376.